Search our database of 500,000 cutting edge ideas.
Join 250,000 entrepreneurs, innovators and CEOs who rely on our weekly trend report to stay ahead of the crowd. You'll get special access to premium content and trend research that cannot be found anywhere else.
The Kary Mullis keynotes offer a thorough examination of the downfalls of antibiotics currently in existence. Mullis believes that the creation of new molecules to which human bodies remain unaccustomed is the answer to the current problem of antibiotics.
Mullis is a 'Nobel Prize' winning chemist and Postdoctoral Fellow at the University of Kansas Medical School. In terms of his education, he holds a Bachelor of Science degree in chemistry form the Georgia Institute of Technology and Ph.D. in biochemistry from the University of California, where he later lectured. Mullis has worked as a DNA Chemist for Cetus Corporation, as the director of molecular biology at Xytronyx and has consulted regularly on the topic of nucleic acid chemistry, in turn solidifying his scientific expertise and enhancing his scientific research.
Currently, Mullis is a Distinguished Researcher at Children's Hospital and Research Institute and sits as a member on various scientific adviser boards. Aside from his impressive credentials, Mullis has also authored several patents and has been awarded one of the most prestigious science awards, the 'Japan Award.'
With stunningly in-depth insight and a personable nature Kary Mullis keynotes introduce breakthrough research methods and approaches to failing health systems.
Featured Keynote - Drug-Resistant Bacteria
A New Cure for Anthrax & Staph is Discussed in the Kary Mullis Keynote
The growing failure of antibiotics in the world today is the focus of this Kary Mullis keynote. The chemist, who has won various awards for his research and breakthroughs in medicine, including the... Read More